Antibiotic Prophylaxis in Urologic Procedures: A Systematic Review

European Urology

Volumn 54, Issue 6, 2008, Pages 1270-1286

  Bootsma, A M Jikke ^a   Laguna Pes, M Pilar ^a   Geerlings, Suzanne E ^b   Goossens, Astrid ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

Author keywords

Antibiotic prophylaxis; Bacteriuria; Infection; Postoperative complications; Urologic interventions

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBENICILLIN; CEFOTAXIME; CEFRADINE; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PIPERACILLIN; PLACEBO; SPARFLOXACIN; TINIDAZOLE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIURIA; BLADDER TUMOR; CYSTECTOMY; DRUG CHOICE; EXTRACORPOREAL LITHOTRIPSY; HUMAN; INFECTION PREVENTION; PERCUTANEOUS NEPHROLITHOTOMY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTHESIS INFECTION; REVIEW; SINGLE DRUG DOSE; SURGICAL WOUND; TRANSURETHRAL RESECTION; URETERORENOSCOPY; URETEROSCOPY; URINARY TRACT INFECTION; URODYNAMICS; UROLOGY; WOUND INFECTION;

ANTIBIOTIC PROPHYLAXIS; HUMANS; UROLOGIC SURGICAL PROCEDURES;

EID: 55749092498     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.03.033     Document Type: Review

References (79)

1. Grabe M. Perioperative antibiotic prophylaxis in urology. Curr Opin Urol 11 (2001) 81-85
2. Grabe M. Controversies in antibiotic prophylaxis in urology. Int J Antimicrob Agents 23 suppl 1 (2004) S17-S23
3. Naber K.G., Hofstetter A.G., Bruhl P., Bichler K., and Lebert C. Guidelines for the perioperative prophylaxis in urological interventions of the urinary and male genital tract. Int J Antimicrob Agents 17 (2001) 321-326
4. Schaeffer E.M. Prophylactic use of antimicrobials in commonly performed outpatient urologic procedures. Nat Clin Pract Urol 3 (2006) 24-31
5. Naber K.G., Bishop M.C., Bjerklund-Johansen T.E., et al. Peri-operative antibacterial prophylaxis in urology. Guidelines on the management of urinary and male genital tract infections. EAU (2006) 100-109
6. Berry A., and Barratt A. Prophylatic antibiotic use in transurethral prostatic resection: a meta-analysis. J Urol 167 (2002) 571-577
7. Qiang W., Jianchen W., MacDonald R., Monga M., and Wilt T.J. Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review. J Urol 173 (2005) 1175-1181
8. Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine Levels of Evidence. Oxford-Centre for Evidence Based Medicine May 2001.
9. Jimenez Cruz J.F., Sanz C.S., Otero G., et al. Antimicrobial prophylaxis in urethrocystoscopy. Comparative study. Actas Urol Esp 17 (1993) 172-175
10. MacDermott J.P., Ewing R.E., Somerville J.F., and Gray B.K. Cephradine prophylaxis in transurethral procedures for carcinoma of the bladder. Br J Urol 62 (1988) 136-139
11. Tsugawa M., Monden K., Nasu Y., Kumon H., and Ohmori H. Prospective randomized comparative study of antibiotic prophylaxis in urethrocystoscopy and urethrocystography. Int J Urol 5 (1998) 441-443
12. Wilson L., Ryan J., Thelning C., Masters J., and Tuckey J. Is antibiotic prophylaxis required for flexible cystoscopy? A truncated randomized double-blind controlled trial. J Endourol 19 (2005) 1006-1008
13. Karmouni T., Bensalah K., Alva A., Patard J.J., Lobel B., and Guille F. Role of antibiotic prophylaxis in ambulatory cystoscopy. Prog Urol 11 (2001) 1239-1241
14. Rane A., Cahill D., Saleemi A., Montgomery B., and Palfrey E. The issue of prophylactic antibiotics prior to flexible cystoscopy. Eur Urol 39 (2001) 212-214
15. Manson A.L. Is antibiotic administration indicated after outpatient cystoscopy. J Urol 140 (1988) 316-317
16. Cundiff G.W., McLennan M.T., and Bent A.E. Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy. Obstet Gynecol 93 (1999) 749-752
17. Ersev D., Dillioglugil O., Ilker Y., Simsek F., and Akdas A. Efficacy of prophylactic gentamicin use in postoperative urinary tract infections after endoscopic procedures of the urinary tract. Urol Int 48 (1992) 401-403
18. Almallah Y.Z., Rennie C.D., Stone J., and Lancashire M.J. Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation. Urology 56 (2000) 37-39
19. Clark K.R., and Higgs M.J. Urinary infection following out-patient flexible cystoscopy. Br J Urol 66 (1990) 503-505
20. Lindert K.A., Kabalin J.N., and Terris M.K. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 164 (2000) 76-80
21. Sharpe J.R., Sadlowski R.W., Finney R.P., Branch W.T., and Hanna J.E. Urinary tract infection after transrectal needle biopsy of the prostate. J Urol 127 (1982) 255-256
22. Akay A.F., Akay H., Aflay U., Sahin H., and Bircan K. Prevention of pain and infective complications after transrectal prostate biopsy: a prospective study. Int Urol Nephrol 38 (2006) 45-48
23. Roach M.B., Figueroa T.E., McBride D., George W.J., and Neal Jr. D.E. Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy. Urology 38 (1991) 84-87
24. Shigemura K., Tanaka K., Yasuda M., et al. Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J Urol 23 (2005) 356-360
25. Tobias-Machado M., Correa T.D., De Barros E.L., and Wroclawski E.R. Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol 29 (2003) 313-319
26. Ruebush T.K., McConville J.H., and Calia F.M. A double-blind study of trimethoprim-sulfamethoxazole prophylaxis in patients having transrectal needle biopsy of the prostate. J Urol 122 (1979) 492-494
27. Aron M., Rajeev T.P., and Gupta N.P. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85 (2000) 682-685
28. Brown R.W., Warner J.J., Turner B.I., Harris L.F., and Alford R.H. Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 18 (1981) 145-148
29. Crawford E.D., Haynes Jr. A.L., Story M.W., and Borden T.A. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 127 (1982) 449-451
30. Isen K., Kupeli B., Sinik Z., Sozen S., and Bozkirli I. Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 31 (1999) 491-495
31. Kapoor D.A., Klimberg I.W., Malek G.H., et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52 (1998) 552-558
32. Melekos M.D. Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol 22 (1990) 257-262
33. Baker K.R., Drutz H.P., and Barnes M.D. Effectiveness of antibiotic prophylaxis in preventing bacteriuria after multichannel urodynamic investigations: a blind, randomized study in 124 female patients. Am J Obstet Gynecol 165 (1991) 679-681
34. Bergman A., and McCarthy T.A. Antibiotic prophylaxis after instrumentation for urodynamic testing. Br J Urol 55 (1983) 568-569
35. Coptcoat M.J., Reed C., Cumming J., Shah P.J., and Worth P.H. Is antibiotic prophylaxis necessary for routine urodynamic investigations? A controlled study in 100 patients. Br J Urol 61 (1988) 302-303
36. Kartal E.D., Yenilmez A., Kiremitci A., Meric H., Kale M., and Usluer G. Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients. Urology 67 (2006) 1149-1153
37. Peschers U.M., Kempf V., Jundt K., Autenrieth I., and Dimpfl T. Antibiotic treatment to prevent urinary tract infections after urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct 12 (2001) 254-257
38. Cutinha P.E., Potts L.K., Fleet C., Rosario D., and Chapple C.R. Morbidity following pressure flow studies. Are prophylactic antibiotics necessary?. Neurourol Urodyn 15 (1996) 304-305
39. Okorocha I., Cumming G., and Gould I. Female urodynamics and lower urinary tract infection. BJU Int 89 (2002) 863-867
40. Onur R., Ozden M., Orhan I., Kalkan A., and Semercioz A. Incidence of bacteraemia after urodynamic study. J Hosp Infect 57 (2004) 241-244
41. Yip S.K., Fung K., Pang M.W., Leung P., Chan D., and Sahota D. A study of female urinary tract infection caused by urodynamic investigation. Am J Obstet Gynecol 190 (2004) 1234-1240
42. Anders K., Cardozo L., Ashman O., and Khullar V. Morbidity after ambulatory urodynamics. Neurourol Urodyn 21 (2002) 461-463
43. Bombieri L., Dance D.A., Rienhardt G.W., Waterfield A., and Freeman R.M. Urinary tract infection after urodynamic studies in women: incidence and natural history. BJU Int 83 (1999) 392-395
44. Brostrom S., Jennum P., and Lose G. Morbidity of urodynamic investigation in healthy women. Int Urogynecol J Pelvic Floor Dysfunct 13 (2002) 182-184
45. Logadottir Y., Dahlstrand C., Fall M., Knutson T., and Peeker R. Invasive urodynamic studies are well tolerated by the patients and associated with a low risk of urinary tract infection. Scand J Urol Nephrol 35 (2001) 459-462
46. Quek P., and Tay L.H. Morbidity and significant bacteriuria after urodynamic studies. Ann Acad Med Singapore 33 (2004) 754-757
47. Klingler H.C., Madersbacher S., Djavan B., Schatzl G., Marberger M., and Schmidbauer C.P. Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol 159 (1998) 191-194
48. Porru D., Madeddu G., Campus G., Montisci I., Scarpa R.M., and Usai E. Evaluation of morbidity of multi-channel pressure-flow studies. Neurourol Urodyn 18 (1999) 647-652
49. Wagenlehner F.M.E., Wagenlehner C., Schinzel S., and Naber K.G. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur Urol 47 (2005) 549-556
50. Rodrigues P., Hering F., Meller A., Campagnari J.C., and D'Imperio M. A randomized and prospective study on the value of antibiotic prophylaxis administration in transurethral resection of the prostate. Sao Paulo Med J 122 (2004) 4-7
51. Upton J.D., and Das S. Prophylactic antibiotics in transurethral resection of bladder tumors: are they necessary?. Urology 27 (1986) 421-423
52. Klimberg I.W., Malek G.H., Cox C.E., Patterson A.L., Whalen E., Kowalsky S.F., et al. Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery. J Antimicrob Chemother 43 suppl A (1999) 77-84
53. Delavierre D., Huiban B., Fournier G., Le G.G., Tande D., and Mangin P. The value of antibiotic prophylaxis in transurethral resection of bladder tumors. Apropos of 61 cases. Prog Urol 3 (1993) 577-582
54. Pearle M.S., and Roehrborn C.G. Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis. Urology 49 (1997) 679-686
55. Pettersson B., and Tiselius H.G. Are prophylactic antibiotics necessary during extracorporeal shockwave lithotripsy?. Br J Urol 63 (1989) 449-452
56. Tominaga T., Tomita K., Shibamoto K., et al. Clinical study of urinary tract infection after treatment with extracorporeal shock-wave lithotriptor. Extracorporeal shock-wave lithotriptor. Nippon Hinyokika Gakkai Zasshi 78 (1987) 1240-1245
57. Bierkens A.F., Hendrikx A.J., Ezz el Din K.E., et al. The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment. Eur Urol 31 (1997) 30-35
58. Claes H., Vandeursen R., and Baert L. Amoxycillin/clavulanate prophylaxis for extracorporeal shock wave lithotripsy-a comparative study. J Antimicrob Chemother 24 suppl B (1989) 217-220
59. Gattegno B., Sicard F., Alcaidinho D., Arnaud E., and Thibault P. Extracorporeal lithotripsy and prophylactic antibiotic therapy. Ann Urol (Paris) 22 (1988) 101-102
60. Ilker Y., Tarcan T., and Akdas A. When should one perform shockwave lithotripsy for lower caliceal stones?. J Endourol 9 (1995) 439-441
61. Herrlinger A., Bornhof C., and Kuehn R. Antibiotic prophylaxis before extracorporeal shock wave lithotripsy by single-shot application of azlocillin. Chemioterapia 6 (1987) 607-609
62. Knipper A., Bohle A., Pensel J., and Hofstetter A.G. Antibiotic prophylaxis with enoxacin in extracorporeal shockwave lithotripsy. Infection 17 suppl 1 (1989) S37-S38
63. Charton M., Vallancien G., Veillon B., Prapotnich D., Mombet A., and Brisset J.M. Use of antibiotics in the conjunction with extracorporeal lithotripsy. Eur Urol 17 (1990) 134-138
64. Deliveliotis C., Giftopoulos A., Koutsokalis G., Raptidis G., and Kostakopoulos A. The necessity of prophylactic antibiotics during extracorporeal shock wave lithotripsy. Int Urol Nephrol 29 (1997) 517-521
65. Dincel C., Ozdiler E., Ozenci H., Tazici N., and Kosar A. Incidence of urinary tract infection in patients without bacteriuria undergoing SWL: comparison of stone types. J Endourol 12 (1998) 1-3
66. Kattan S., Husain I., el-Faqih S.R., and Atassi R. Incidence of bacteremia and bacteriuria in patients with non-infection-related urinary stones undergoing extracorporeal shock wave lithotripsy. J Endourol 7 (1993) 449-451
67. Raz R., Zoabi A., Sudarsky M., and Shental J. The incidence of urinary tract infection in patients without bacteriuria who underwent extracorporeal shock wave lithotripsy. J Urol 151 (1994) 329-330
68. Fourcade R.O. Antibiotic prophylaxis with cefotaxime in endoscopic extraction of upper urinary tract stones: a randomized study. The Cefotaxime Cooperative Group. J Antimicrob Chemother 26 suppl A (1990) 77-83
69. Knopf H.-J., Graff H.-J., and Schulze H. Perioperative antibiotic prophylaxis in ureteroscopic stone removal. Eur Urol 44 (2003) 115-118
70. Charton M., Vallancien G., Veillon B., and Brisset J.M. Urinary tract infection in percutaneous surgery for renal calculi. J Urol 135 (1986) 15-17
71. Osman M., Wendt-Nordahl G., Heger K., Michel M.S., Alken P., and Knoll T. Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int 96 (2005) 875-878
72. Dogan H.S., Sahin A., Cetinkaya Y., Akdogan B., Ozden E., and Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol 16 (2002) 649-653
73. Cutajar C.L. Norfloxacin prophylaxis for endoscopic urological surgery. Br J Urol 69 (1992) 421-424
74. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., and Jarvis W.R. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27 (1999) 97-132
75. Rassweiler J., Fornara P., Weber M., et al. Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol 160 (1998) 18-21
76. Fahlenkamp D., Rassweiler J., Fornara P., Frede T., and Loening S.A. Complication of laparoscopic procedures in urology: experience with 2,407 procedures at 4 German centers. J Urol 162 (1999) 765-770
77. Colombo Jr. J.R., Haber G.P., Jelovsek J.E., et al. Complications of laparoscopic surgery for urological cancer: a single institution analysis. J Urol 178 (2007) 786-791
78. Frei C.R., Restrepo M.I., Mortensen E.M., and Burgess D.S. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 119 (2006) 865-871
79. Menendez R., Torres A., Zalacain R., et al. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 172 (2005) 757-762